NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 350 filers reported holding NATERA INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,128 | -3.4% | 1,969 | +6.3% | 0.01% | 0.0% |
| Q2 2023 | $90,167 | +19.2% | 1,853 | +36.0% | 0.01% | +14.3% |
| Q1 2023 | $75,674 | -94.1% | 1,363 | -95.8% | 0.01% | -94.8% |
| Q4 2022 | $1,288,332 | -24.6% | 32,072 | -17.8% | 0.13% | -23.0% |
| Q3 2022 | $1,709,000 | +64.8% | 39,005 | +33.4% | 0.17% | +68.9% |
| Q2 2022 | $1,037,000 | -11.8% | 29,247 | +1.2% | 0.10% | +3.0% |
| Q1 2022 | $1,176,000 | -79.4% | 28,910 | -52.6% | 0.10% | -78.3% |
| Q4 2021 | $5,698,000 | -14.6% | 61,014 | +1.9% | 0.46% | -22.8% |
| Q3 2021 | $6,671,000 | +1.4% | 59,862 | +3.3% | 0.60% | -1.6% |
| Q2 2021 | $6,581,000 | -0.9% | 57,969 | -11.4% | 0.61% | -6.6% |
| Q1 2021 | $6,643,000 | +84.3% | 65,425 | +80.6% | 0.65% | +69.7% |
| Q4 2020 | $3,604,000 | +15.9% | 36,217 | -15.9% | 0.38% | -0.5% |
| Q3 2020 | $3,110,000 | +90.4% | 43,057 | +31.5% | 0.38% | +92.5% |
| Q2 2020 | $1,633,000 | +140.9% | 32,742 | +44.3% | 0.20% | +132.6% |
| Q1 2020 | $678,000 | – | 22,693 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |